The GCCP scorecard will illustrate how selected companies are performing on the 18 selected good practices. There are 18 good practices that pharmaceutical developers/manufacturers of Covid-19 vaccines & therapeutics should undertake to align their actions with human rights principles and international standards for equitable access to medicines.
Tag: GCCP Score card
EVENT: Discussing pharmaceutical human rights accountability during Covid-19
FtV Projectcoordinator -
An International Expert Panel Discussion on Good Covid-19 Company Practices (GCCP)
The Pharmaceutical Accountability Foundation is organising an event on its Good Covid-19 Company Practices (GCCP) project on september 30th 2021, 15:00-16:30 CET.
The event will be an introduction to the GCCP and what we have learned so far on how...
The Pharmaceutical Accountability Foundation scores pharmaceutical companies’ behaviour regarding Covid-19 in a GCCP Scorecard. Conclusion: Big differences in adherence to human rights principles
Farma ter Verantwoording -
Bergeijk, 22 January 2021 – Pharmaceutical Accountability Foundation (PAF) publishes a GCCP scorecard of pharmaceutical companies that develop important vaccines and pharmaceuticals for the Corona pandemic.
“Despite their almost unanimous endorsement of human rights principles that ensure fair, global access to vaccines and pharmaceuticals, in reality, companies’ behaviour does not...
Licensed under Creative Commons (CC BY-NC-SA 4.0), The Pharmaceutical Accountability Foundation 2022